BackTransmedics Group Overview
Transmedics Group Inc

Transmedics Group Debt to Equity

Latest debt-to-equity ratio for Transmedics Group: 1.68 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

1.68

Debt to Equity

1.68

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Transmedics Group (TMDX) FAQ

Transmedics Group's debt-to-equity ratio stands at 1.68. That is above the Healthcare sector average of 0.28. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Transmedics Group sits higher the Healthcare benchmark (0.28) with a debt-to-equity ratio of 1.68. That is roughly 507.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 1.68 is attractive depends on Transmedics Group's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Transmedics Group's debt-to-equity ratio evolved across reporting periods, while the comparison chart places TMDX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, debt-to-equity ratio is commonly used to spot outliers. Transmedics Group's reading of 1.68 (sector avg 0.28) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.